Anzeige
Mehr »
Samstag, 16.08.2025 - Börsentäglich über 12.000 News
Neue Bohrergebnisse, Sichtgold und eine 7-fache Bewertungslücke, die zu groß ist, um sie zu ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XZH | ISIN: FR0012882389 | Ticker-Symbol: PHF
Tradegate
15.08.25 | 16:03
49,350 Euro
-0,80 % -0,400
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
EQUASENS SA Chart 1 Jahr
5-Tage-Chart
EQUASENS SA 5-Tage-Chart
RealtimeGeldBriefZeit
49,50049,75013:02
49,65049,85015.08.

Aktuelle News zur EQUASENS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
31.07.Equasens: H1 revenue at 30 June 2025: €116.0m308Villers-lès-Nancy (France), 31 July 2025 - 6:00 PM (CET) PRESS RELEASE H1 revenue at 30 June 2025: €116.0m+7.4% on a reported basis and +6.4% like-for-like H1 2025 Group revenue (€m)2024Reported...
► Artikel lesen
03.07.Equasens: Appointment at the head of the Pharmagest Division220Villers-lès-Nancy (France), July 03, 2025 - 06:00pm (CET) Press Release Equasens announces the departure of Damien VALICON, as Deputy Chief Executive Officer and Director of the Pharmagest Division...
► Artikel lesen
02.07.Dividendenbekanntmachungen (02.07.2025)7.991 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AECOM  US00766T1007  0,26 USD  0,2202 EUR  AMADEUS IT GROUP SA  ES0109067019 - 0,89 EUR  ASSECO SOUTH EASTERN EUROPE SA  PLASSEE00014  1...
► Artikel lesen
01.07.Equasens: General meeting - Results of the votes165Villers-lès-Nancy, 1st July 2025 - 07:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2025 Number of shares comprising...
► Artikel lesen
30.06.Equasens: acquisition of DIS and RESURGENCES BUSINESSES301Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET) PRESS RELEASE EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE...
► Artikel lesen
06.06.Equasens: availability of AGM preparatory materials1
12.05.Equasens: Q1 revenue at 31 March 2025399Villers-lès-Nancy, 12 May 2025 - 6:00 PM (CET) PRESS RELEASE Q1 revenue at 31 March 2025: €57.0m+ 6.9% growth on a reported basis and + 5.9% like-for-like Q1 2025 REVENUE (€m)2024Reported basis2025Reported...
► Artikel lesen
28.03.Equasens: 2024 annual results421Villers-lès-Nancy, 28 March 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual results Full-year results adversely affected by difficult economic conditions in H1 combined with continuing investment...
► Artikel lesen
EQUASENS Aktie jetzt für 0€ handeln
06.03.Softwareanbieter: Von Prisma/Narz zu Pharmagest5
06.02.Equasens: 2024 annual revenue379Villers-lès-Nancy, 6 February 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual revenue: €216.8 million including €58.6 million in Q4 (+2.6% on a reported basis and -0.4% like-for-like) Revenue (€&)2023Reported...
► Artikel lesen
27.12.24Equasens: Strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons773Villers-lès-Nancy, 27 December 2024 - 6:00 p.m. (CET)PRESS RELEASE Equasens strengthens its presence in the healthcare software market with the strategic acquisition of Calimed, a SaaS software expert...
► Artikel lesen
07.11.24Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)934Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 nine-month revenue: €158.2 million Return to growth in Q3 (+0.3%) Revenue (€m) 2023Reported basis...
► Artikel lesen
27.09.24Equasens: 2024 half-year results508Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 half-year results Group results impacted by weaker economic conditions and continuing investment efforts in H1: Revenue:...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1